ArticleCase reports in oncology
A Rare Case of Adenoid Cystic Breast Cancer: A Case Report and Literature Review.
Article in Case reports in oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Adenoid cystic carcinoma (AdCC) of the breast is an exceptionally rare malignancy, representing less than 0.1% of all breast cancers. Despite its triple-negative receptor profile, it typically follows an indolent course with excellent prognosis, distinct from the aggressive behavior usually seen in triple-negative breast cancers (TNBCs). Case Presentation: We report the case of a 48-year-old woman with a significant familial history of cancer who was diagnosed with breast AdCC. Imaging revealed a suspicious lesion in the left breast, and biopsy confirmed AdCC. Surgical resection showed a 58-mm, pT3, pN0(sn) triple-negative tumor with a low proliferative index. Genetic testing revealed a BRIP1 variant of uncertain significance (VUS). No adjuvant chemotherapy was given, and the patient remains in remission under surveillance. Discussion: This case highlights the diagnostic challenges of AdCC, including its resemblance to benign lesions on imaging and its overlap with high-grade TNBC histologically. While most AdCC cases are sporadic, the presence of a BRIP1 VUS in a patient with strong family history raises questions about possible hereditary implications. Management was based on current best practices, emphasizing surgical resection and selective use of radiotherapy. Conclusion: Breast AdCC, though rare, requires heightened clinical awareness for accurate diagnosis and management. This case underscores the potential role of genetic evaluation in rare breast cancer subtypes and the importance of continued case reporting to guide future recommendations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.